EDGAR Filing Documents for 0001169245-21-000076

Form 8-K - Current report:

SEC Accession No. 0001169245-21-000076

Filing Date

2021-08-12

Accepted

2021-08-12 10:11:38

Documents

Period of Report

2021-08-12

Items

Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a8-kx81221.htm	8-K	29327
2	EX-99.1	phasebio_q22021financialsd.htm	EX-99.1	72100
3	EX-99.2	phasebiocorporateovervie.htm	EX-99.2	48148
4	EX-99.3	phasebiointerimanalysisenr.htm	EX-99.3	20337
5		image_0.jpg	GRAPHIC	914863
6		image_01.jpg	GRAPHIC	914863
7		image_1.jpg	GRAPHIC	69
8	GRAPHIC	phasebiocorporateovervie001.jpg	GRAPHIC	67124
9	GRAPHIC	phasebiocorporateovervie002.jpg	GRAPHIC	190147
10	GRAPHIC	phasebiocorporateovervie003.jpg	GRAPHIC	145230
11	GRAPHIC	phasebiocorporateovervie004.jpg	GRAPHIC	113030
12	GRAPHIC	phasebiocorporateovervie005.jpg	GRAPHIC	35457
13	GRAPHIC	phasebiocorporateovervie006.jpg	GRAPHIC	128626
14	GRAPHIC	phasebiocorporateovervie007.jpg	GRAPHIC	109538
15	GRAPHIC	phasebiocorporateovervie008.jpg	GRAPHIC	86306
16	GRAPHIC	phasebiocorporateovervie009.jpg	GRAPHIC	47376
17	GRAPHIC	phasebiocorporateovervie010.jpg	GRAPHIC	141039
18	GRAPHIC	phasebiocorporateovervie011.jpg	GRAPHIC	96981
19	GRAPHIC	phasebiocorporateovervie012.jpg	GRAPHIC	123188
20	GRAPHIC	phasebiocorporateovervie013.jpg	GRAPHIC	112485
21	GRAPHIC	phasebiocorporateovervie014.jpg	GRAPHIC	127804
22	GRAPHIC	phasebiocorporateovervie015.jpg	GRAPHIC	152272
23	GRAPHIC	phasebiocorporateovervie016.jpg	GRAPHIC	133884
24	GRAPHIC	phasebiocorporateovervie017.jpg	GRAPHIC	120367
25	GRAPHIC	phasebiocorporateovervie018.jpg	GRAPHIC	132555
26	GRAPHIC	phasebiocorporateovervie019.jpg	GRAPHIC	149151
27	GRAPHIC	phasebiocorporateovervie020.jpg	GRAPHIC	136649
28	GRAPHIC	phasebiocorporateovervie021.jpg	GRAPHIC	154990
29	GRAPHIC	phasebiocorporateovervie022.jpg	GRAPHIC	136607
30	GRAPHIC	phasebiocorporateovervie023.jpg	GRAPHIC	104634
31	GRAPHIC	phasebiocorporateovervie024.jpg	GRAPHIC	109335
32	GRAPHIC	phasebiocorporateovervie025.jpg	GRAPHIC	102857
33	GRAPHIC	phasebiocorporateovervie026.jpg	GRAPHIC	58755
34	GRAPHIC	phasebiocorporateovervie027.jpg	GRAPHIC	96173
35	GRAPHIC	phasebiocorporateovervie028.jpg	GRAPHIC	112871
36	GRAPHIC	phasebiocorporateovervie029.jpg	GRAPHIC	112873
37	GRAPHIC	phasebiocorporateovervie030.jpg	GRAPHIC	120256
38	GRAPHIC	phasebiocorporateovervie031.jpg	GRAPHIC	51017
39	GRAPHIC	phasebiocorporateovervie032.jpg	GRAPHIC	145335
40	GRAPHIC	phasebiocorporateovervie033.jpg	GRAPHIC	123343
41	GRAPHIC	phasebiocorporateovervie034.jpg	GRAPHIC	59935
	Complete submission text file	0001169245-21-000076.txt		7895498

Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355

Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500

PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)